Abbott Laboratories buy Piper Sandler
Start price
17.04.25
/
50%
€116.00
Target price
17.04.26
€127.60
Performance (%)
-26.29%
Price
10.04.26
€85.50
This prediction will end soon
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -26.29%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by Piper_Sandler for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $145.00 price target on the stock, up previously from $133.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Piper_Sandler for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€114.93
23.01.27
23.01.27
-8.08%
10.04.26
10.04.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€109.48
17.10.24
17.10.24
€122.61
17.10.25
17.10.25
0.46%
18.10.25
18.10.25
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.70
19.09.24
19.09.24
€117.72
19.09.25
19.09.25
12.09%
20.09.25
20.09.25